Reduced hemoglobin after heart transplantation is no independent risk factor for survival but is associated closely with impaired renal function

被引:24
作者
Gleissner, CA
Murat, A
Schäfer, S
Klingenberg, R
Koch, A
Remppis, A
Zimmermann, R
Katus, HA
Dengler, TJ
机构
[1] Heidelberg Univ, Dept Cardiol Angiol & Pneumonol, D-69115 Heidelberg, Germany
[2] IST GmbH, Mannheim, Germany
[3] Heidelberg Univ, Dept Cardiac Surg, D-6900 Heidelberg, Germany
关键词
D O I
10.1097/01.TP.0000116443.64958.88
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Reduced hemoglobin (Hb) levels after heart transplantation (HTX) are common; however, there are only limited data on the association of posttransplant anemia with survival. Methods. In the present study, the effect of Hb levels determined 7 to 12 months after HTX on survival was investigated in 156 heart transplant recipients (129 men and 27 women; age at transplantation, 51.3 +/- 10.45 years; follow-up, 6.77 +/- 3.6 years) by univariate and multivariate analyses including a broad range of clinical and demographic patient characteristics. Results. Anemia by standard definition was found in 141 of 156 (91.6%) patients. According to Hb levels above or below the gender-specific median (men, 12.07 g/dL; women, 11.69 g/dL), patients were separated into a high- or low-Hb group, respectively. Kaplan-Meier analysis demonstrated significantly worse survival in the low-Hb group (P=0.033). Those patients showed significantly lower body weight, higher serum creatinine levels, and lower calculated creatinine clearance; the association of creatinine clearance and Hb levels was highly significant (P < 0.0001). No differences were demonstrated between groups for age, preoperative cardiac diagnosis, diabetes, azathioprine, steroid or angiotensin-converting enzyme inhibitor medication, leukocyte and thrombocyte levels, rejection index, or cytomegalovirus (CMV) infection or serostatus. Multivariate Cox stepwise regression analysis demonstrated that CMV infection, diabetes, and female donor gender were significant risk factors for post-HTX survival. An Hb level below the median was, however, completely lost as a risk factor (P=0.44); instead, a strong trend for reduced creatinine clearance could be demonstrated (P=0.09). Subsequently, a significant association was demonstrated between low calculatedcreatinine clearance and impaired survival by separate Kaplan-Meier analysis (P=0.02). Conclusions. Low Hb levels after HTX do not represent an independent risk factor for reduced survival, but the demonstrated correlation appears to be primarily caused by concomitant functional renal impairment. Further studies will be required to investigate the role of post-HTX anemia as a sensitive indicator of functional renal impairment and the effects of anemia treatment on long-term survival.
引用
收藏
页码:710 / 717
页数:8
相关论文
共 18 条
[1]   The effect of pre-existing ischaemic heart disease on renal dysfunction in cardiac transplant recipients [J].
Abraham, KA ;
McGorrian, C ;
O'Kelly, P ;
Neligan, M ;
Woods, AE ;
Conlon, PJ ;
Donohoe, J .
AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (04) :355-359
[2]   Effect of anemia on 1-year mortality in patients with acute myocardial infarction [J].
Al Falluji, N ;
Lawrence-Nelson, J ;
Kostis, JB ;
Lacy, CR ;
Ranjan, R ;
Wilson, AC .
AMERICAN HEART JOURNAL, 2002, 144 (04) :636-641
[3]  
BEGUIN Y, 1993, BLOOD, V81, P1067
[4]  
Billingham M E, 1990, J Heart Transplant, V9, P587
[5]  
BRAUNWALD E, 2001, HARRISONS PRINCIPLES, P1181
[6]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[7]   Anemia is common in heart failure and is associated with poor outcomes - Insights from a cohort of 12,065 patients with new-onset heart failure [J].
Ezekowitz, JA ;
McAlister, FA ;
Armstrong, PW .
CIRCULATION, 2003, 107 (02) :223-225
[8]  
FROST AE, 1993, TRANSPLANTATION, V56, P1008
[9]   Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure [J].
Hayashi, T ;
Suzuki, A ;
Shoji, T ;
Togawa, M ;
Okada, N ;
Tsubakihara, Y ;
Imai, E ;
Hori, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (02) :250-256
[10]   Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization [J].
Heeschen, C ;
Aicher, A ;
Lehmann, R ;
Fichtischerer, S ;
Vasa, M ;
Urbich, C ;
Mildner-Rihm, C ;
Martin, H ;
Zeiher, AM ;
Dimmeler, S .
BLOOD, 2003, 102 (04) :1340-1346